AbbVie Inc. /
Apogee Therapeutics, Inc.
AbbVie Inc. completed its deal for Apogee Therapeutics, Inc.
Source for the buyer and target: Apogee Therapeutics, Inc.
For the buyer and target.
“As previously disclosed, on June 18, 2026, Apogee Therapeutics, Inc., a Delaware corporation (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Andor LLC, a Delaware limited liability company and a wholly owned subsidiary of Guarantor (“Parent”), Andor Merger Co., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and solely for the limited purposes set forth therein, AbbVie Inc., a Delaware corporation (“Guarantor” or “AbbVie”).”
Published 3 Sep 2026
Open the sourceWhat happened
The deal for Apogee Therapeutics, Inc. has closed, with AbbVie Inc. as the buyer, at a stated price of approximately $10.9 billion. [01]
The filing from Apogee Therapeutics, Inc. is dated Sept. 3, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
AbbVie Inc. completed its deal for Apogee Therapeutics, Inc.
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly